Results 121 to 130 of about 52,283 (260)

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Journal of Internal Medicine, Volume 300, Issue 5, Page 590-609, November 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund, Johanna Melin, Anju E. Joham, Terhi T. Piltonen, D. Aled Rees, Helena J. Teede   +5 more
wiley   +1 more source

The MexMAGIC population reveals the genetic architecture of traits exhibiting clinal variation in Mexican native maize

New Phytologist, Volume 252, Issue 3, Page 1296-1313, November 2026.
The MexMAGIC population mixes native maize varieties from across Mexico to study functional genetic diversity. Summary Defining the genetic basis of local adaptation is a key goal of evolutionary biology and crop improvement. Theory predicts that when selective pressures follow differences in the environment, a cline will be established.
Sergio Perez‐Limón, Ana Laura Alonso‐Nieves, M. Rosario Ramírez‐Flores, G. Carolina Cintora‐Martínez, M. Nancy Salazar‐Vidal, Jorge Vladimir Torres‐Rodriguez, Jessica Carcaño‐Macías, Melanie G. Perryman, Oliver H. S. Paulson, Jagdeep S. Sidhu, Peng Yu, Victor Llaca, Kevin A. Fengler, Forrest Li, Daniel E. Runcie, Jeffrey Ross‐Ibarra, C. Stewart Gillmor, Rubén Rellán‐Álvarez, Ruairidh J. H. Sawers   +18 more
wiley   +1 more source

Non-clinical symptoms associated with polycystic ovary syndrome: evidence from a comparative study in Bangladesh. [PDF]

J Glob Health
Tanvir KM, Hossain SS, Turin HM, Mahiuddin M, Ara T, Faiza M, Islam M, Sabbir A, Biswas MR, Islam T, Khan T, Ether ST, Hossain IA, Ahmed A.   +13 more
europepmc   +1 more source

Low Weight Loss Response to Incretin Analogs: A Systematic Review

Obesity Reviews, Volume 27, Issue 11, November 2026.
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley   +1 more source

Climate Change Induced Seasonal Amplification of the Indian Ocean CO2 Sink

Geophysical Research Letters, Volume 53, Issue 19, 16 October 2026.
Abstract This study investigates changes in the mean and seasonal states of oceanic carbon uptake across the Indian Ocean (IO) using an improved, high‐resolution, observationally constrained long‐term (1980–2019) surface ocean pCO2 ${\text{pCO}}_{2}$ data product.
A. P. Joshi, Kunal Chakraborty, V. V. S. S. Sarma, Prasanna Kanti Ghoshal, B. Sridevi, Zouhair Lachkar   +5 more
wiley   +1 more source

PCOS and bone fractures [PDF]

Journal of Bone and Mineral Metabolism, 2018
Fabio V, Comim, Melissa O, Premaor
openaire   +2 more sources

NR4A1‐Driven Granulosa Cell Ferroptosis Contributes to Obesity‐Related Ovarian Dysfunction and Metformin‐Mediated Ovarian Protection

The FASEB Journal, Volume 40, Issue 19, 15 October 2026.
Schematic illustrating that NR4A1‐driven granulosa cell ferroptosis mediates obesity‐related ovarian dysfunction, while metformin‐mediated ovarian protection is achieved via suppression of the PI3K/AKT–NR4A1 ferroptotic signaling cascade. ABSTRACT Obesity triggers ovarian dysfunction and female infertility accompanied by granulosa cell damage ...
Huihui Wang, Chaoying Wang, Shuaishuai Guo, Guang Yang, Junnan Fang, Jingyi Hu, Ran Jiang, Jun Zhai, Haixia Jin, Wenyan Song, Senlin Shi, Xianju Huang, Lin Qi, Zhaoting Wu, Yan Liu, Ning Song, Xiangyang Zhang, Guidong Yao   +17 more
wiley   +1 more source

Streamlining Diagnosis of Bardet–Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria

American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2181-2198, October 2026.
ABSTRACT Considerable advances have been made in our understanding of Bardet–Biedl syndrome (BBS), particularly in its core clinical features and molecular genetics, warranting an update to the existing diagnostic criteria framework. Using a rigorous, evidence‐based, and consensus‐driven process, a multidisciplinary group of international experts and ...
Jeremy J. Pomeroy, Jesse Richards, Brooke R. Sweeney, Seema Kumar, Katie E. Queen, Joshua Zaritsky, Carl H. Cramer, Elias I. Traboulsi, Brittni A. Scruggs, Erica E. Davis, Ekaterina Keifer, Emma McGibbon, Timothy Ogden, Bendert De Graaf, Tonia Hymers, Elizabeth Forsythe, Philip Beales   +16 more
wiley   +1 more source

Oocyte–cumulus cell interaction: a key factor in early embryo development

Biological Reviews, Volume 101, Issue 5, Page 2265-2278, October 2026.
ABSTRACT The evaluation of oocyte competence is a fundamental step in achieving successful outcomes following assisted reproduction techniques (ART). At present, however, conventional oocyte maturation assessment is carried out by morphological observation, which is a subjective method that does not consider molecular features.
Marc Torres‐Garrido, Marc Yeste, Yentel Mateo‐Otero   +2 more
wiley   +1 more source

Network Pharmacology and In Vivo Evaluation of Modified Huanglian Wendan Decoction in Polycystic Ovary Syndrome With Insulin Resistance: Association With AGE–RAGE‐Related Signaling

Chemistry &Biodiversity, Volume 23, Issue 10, October 2026.
An integrated network pharmacology, chemical profiling, molecular docking, molecular dynamics, and in vivo strategy shows that Modified Huanglian Wendan Decoction improves reproductive and metabolic abnormalities in a rat model of PCOS with insulin resistance.
Xi Chen, Xing Yang, Xinni Wang, Dan Chou, Chenghong Zheng   +4 more
wiley   +1 more source